Skip to main content
. 2018 Apr 6;10(4):454. doi: 10.3390/nu10040454

Figure 3.

Figure 3

Arachidonic acid (AA) and docosahexaenoic acid (DHA) modulate conventional and atypical PKC activities in U87 cells expressing B-FABP. Two-way effect plot of least square mean PKC activity (y axis) calculated as percentage of U87 control BSA-treated cells vs treatment (x axis) for (a) conventional PKC activity; (b) novel PKC activity; and (c) atypical PKC activity measured in U87 cells transfected with either empty pREP4 vector (U87 Control) or a pREP4-FABP7 expression construct (U87 B-FABP). Cells were treated with 60 µM BSA, 60 µM AA, or 60 µM DHA (n = 3–6/treatment). # indicates differences relative to the U87 control from the corresponding treatment group and * indicates a difference in the effect of the treatment for the same cell type.